Cosmo Files Second Patent Suit Against Actavis Over Generic Uceris

Drug Industry Daily
A A
Cosmo Technologies filed a second lawsuit against Actavis alleging the drugmaker infringed upon Cosmo’s patent with its newly approved generic for the colitis drug Uceris (budesonide).

To View This Article:

Login

Subscribe To Drug Industry Daily